Twist Bioscience launches synthetic RNA control for H5N1 Influenza A

Twist Bioscience announced the expansion of its growing portfolio of synthetic viral controls with the launch of a synthetic RNA control for H5N1 Influenza A, which is one of the causes of Highly Pathogenic Avian Influenza HPAI or bird flu, covering 99.9% of hemagglutinin HA and neuraminidase NA genome regions. “As agricultural and infectious disease researchers around the world continue to monitor the spread of H5N1, we continue our unwavering commitment to responding rapidly to threats to public health by providing innovative and critical tools to safeguard our global community and enable monitoring and surveillance as well as vaccine and assay development,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. ”